Short answer
Aldeyra Therapeutics, Inc. (ALDX) filed an 8-K current report with the SEC on July 30, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). New corporate headquarters lease for approximately 4,067 square feet in Concord, Massachusetts.
Aldeyra Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- New corporate headquarters lease for approximately 4,067 square feet in Concord, Massachusetts
- Lease term: September 1, 2026 through September 30, 2029
- Base rent $12,201 monthly, with annual increases and additional operating expenses, taxes, and fees
- Initial security deposit of $50,000, creating a modest near-term cash commitment
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aldeyra Therapeutics, Inc. 8-K filings
Get the next ALDX 8-K as it lands
Follow ALDX for push alerts, or ask the research agent what this filing means.